Our News

Our companies and we are trying to stay at forefront of innovation with the goal to save and improve patients' lives. We are glad to share our progress on the way to achieving this goal.

January 2020

Eyevensys Closes $30M Series B Financing

July 2019

AM-Pharma raises EUR 116 mn to conduct pivotal Phase III Trial of recAP in Acute Kidney Injury

April 2019

BB Pureos Bioventures (Pureos) co-led a CHF 12.5 million investment in Alentis Therapeutics AG

March 2019

NovaGo Therapeutics raises CHF 10 million to develop regenerative anti-Nogo therapy for stroke

June 2018

Hochkarätiger Beirat für neue Risikokapitalgesellschaft BB Pureos Bioventures

May 2018

NZZ.ch - Fünf Fragen an Dominik Escher

April 2018

NZZ.ch - Im Biotech-Sektor klafft eine Finanzierungslücke

February 2018

Agéfi - Pureos Bioventures se focalise sur les biotechs actives dans la recherche de médicaments

February 2018

Initative for venture capital in Switzerland